早期乳腺癌老年患者的时间变化效应:基于时间尺度考虑竞争风险的模型
Zhiyin Yu1, Xiang Geng1, Zhaojin Li1
1Department of Biostatistics, School of Public Health (Guangdong Provincial Key Laboratory of Tropical Disease Research), Southern Medical University, Guangzhou, China.
Frontiers in oncology
|July 17, 2024
概括
这项研究引入了一个新的动态回归模型,用于早期乳腺癌患者,这些患者面临着竞争性风险. 该模型使用受限平均损失时间 (RMTL),揭示了预后因素随着时间的推移而发生的变化,从而提供了改进的预测.
科学领域:
- 在瘤学瘤学.
- 生物统计学 生物统计学
- 流行病学 流行病学
背景情况:
- 早期乳腺癌患者面临来自其他疾病的死亡风险.
- 采用分发危险比率的传统竞争性风险模型在临床解释和静态评估方面存在局限性.
- 乳腺癌的预后因素可以在长期随访中表现出动态的,时间变化的影响.
研究的目的:
- 开发一种新的回归模型,以考虑乳腺癌预后因素的动态影响.
- 用一种直观的绝对度量来量化预后因素的影响:受限平均时间损失 (RMTL).
- 在存在竞争风险的情况下,提供更准确和个性化的预测.
主要方法:
- 提出了一个动态效应RMTL回归模型.
- 该模型探讨了平均损失时间和实时效应的累积差异.
- 利用模拟进行验证,并将模型应用于较老的早期乳腺癌队列.
主要成果:
- 模拟证实了系数估计的准确性.
- 观察到的时间变化的效应:雌激素受体和化疗的保护作用下降,而乳腺保护手术的效果增加.
- 晚期瘤 (T2,N2) 和更高等级 (II) 癌症的有害影响也随着时间的推移而增加.
- 在对预测准确性的外部验证中获得了0.78的平均C指数.
结论:
- 动态效应RMTL回归提供了一个全面的方法来分析竞争风险场景中的时间变化的协变量效应.
- 与静态模型相比,这种方法提供了更准确的预测和增强的预测能力.
- 这些发现强调了考虑动态效应对于个性化乳腺癌管理的重要性.
相关概念视频
01:21Cancer Survival Analysis
336
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
336
01:20Comparing the Survival Analysis of Two or More Groups
172
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
172
01:15Assumptions of Survival Analysis
120
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
120
01:20Actuarial Approach
72
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
72
01:18Introduction To Survival Analysis
203
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
203
01:24Kaplan-Meier Approach
119
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
119